Stefano Altomonte
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Publications (10 Years): 4
Top Venues
Publications
- Stefano Altomonte, Xuefeng Yan, Cheryl L Morse, Jeih-San Liow, Madeline D Jenkins, Jose A Montero Santamaria, Sami S Zoghbi, Robert B Innis, Victor W PikeDiscovery of a High-Affinity Fluoromethyl Analog of [ 11 C]5-Cyano- N -(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([ 11 C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography Radioligands. ACS pharmacology & translational science 6 (4) (2023)
- Stefano Altomonte, Xuefeng Yan, Cheryl L Morse, Jeih-San Liow, Madeline D Jenkins, Jose A Montero Santamaria, Sami S Zoghbi, Robert B Innis, Victor W PikeDiscovery of a High-Affinity Fluoromethyl Analog of [ 11 C]5-Cyano- N -(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([ 11 C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography Radioligands. ACS pharmacology & translational science 6 (4) (2023)
- Stefano Altomonte, Xuefeng Yan, Cheryl L Morse, Jeih-San Liow, Madeline D Jenkins, Jose A Montero Santamaria, Sami S Zoghbi, Robert B Innis, Victor W PikeDiscovery of a High-Affinity Fluoromethyl Analog of [ 11 C]5-Cyano- N -(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([ 11 C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography Radioligands. ACS pharmacology & translational science 6 (4) (2023)
- Stefano Altomonte, Xuefeng Yan, Cheryl L Morse, Jeih-San Liow, Madeline D Jenkins, Jose A Montero Santamaria, Sami S Zoghbi, Robert B Innis, Victor W PikeDiscovery of a High-Affinity Fluoromethyl Analog of [ 11 C]5-Cyano- N -(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([ 11 C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography Radioligands. ACS pharmacology & translational science 6 (4) (2023)